DrugDashboards

Ketorolac Tromethamine

Ketorolac Tromethamine · KETOROLAC TROMETHAMINE 30 mg/mL · Injection · Intramuscular; Intravenous · Medical Purchasing Solutions, LLC

NDC 71872-7327-01 · 1 VIAL in 1 BAG / 1 mL in 1 VIAL · ANDA · View full market →

The short version

9 companies supply this market — a reasonable cushion if one runs into trouble. It is in shortage right now — FDA lists the reason as “other.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for ketorolac tromethamine (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $22.07 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA214456
TE code
AP
Approval date
Nov 2, 2022
Patents / exclusivity
None on file

Shortage history

  • In shortage now Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25)Jun 6, 2018
    Other
    month 99 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25)Jun 6, 2018
    Other
    month 99 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25)Jun 6, 2018
    Other
    month 99 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25)Mar 23, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 62332-600-25)Mar 23, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25)Mar 23, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Ketorolac Tromethamine (Injection)

LabelerStrengthFirst seenLast seen
Onesource Specialty Pharma LimitedKETOROLAC TROMETHAMINE 60 mg/2mLJul 15, 2026Sep 3, 2026
Onesource Specialty Pharma LimitedKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 3, 2026
Onesource Specialty Pharma LimitedKETOROLAC TROMETHAMINE 15 mg/mLJul 15, 2026Sep 3, 2026
A-S Medication SolutionsKETOROLAC TROMETHAMINE 15 mg/mLJul 15, 2026Sep 2, 2026
A-S Medication SolutionsKETOROLAC TROMETHAMINE 60 mg/2mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.KETOROLAC TROMETHAMINE 15 mg/mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.KETOROLAC TROMETHAMINE 60 mg/2mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.KETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.KETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.KETOROLAC TROMETHAMINE 15 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCKETOROLAC TROMETHAMINE 60 mg/2mLJul 15, 2026Sep 2, 2026
Nephron Pharmaceuticals CorporationKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 2, 2026
SOLA Pharmaceuticals, LLCKETOROLAC TROMETHAMINE 15 mg/mLJul 15, 2026Sep 2, 2026
SOLA Pharmaceuticals, LLCKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 2, 2026
Sportpharm LLCKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.KETOROLAC TROMETHAMINE 15 mg/mLJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.KETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.KETOROLAC TROMETHAMINE 60 mg/2mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Ketorolac Tromethamine — NDC 71872-7327-01," retrieved September 3, 2026, https://drugdashboards.com/drug/71872732701.

Free to cite with attribution — see how the data is put together.